The metabolic syndrome in cancer survivors

Esther C. de Haas; Sjoukje F. Oosting; Joop D. Lefrandt; Bruce H. R. Wolffenbuttel; Dirk Th Sleijfer; Jourik A. Gietema

The metabolic syndrome in cancer survivors

Esther C. de Haas, Sjoukje F. Oosting, Joop D. Lefrandt, Bruce H. R. Wolffenbuttel, Dirk Th Sleijfer, Jourik A. Gietema^*

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput: Review article › peer review

154 Citaten (Scopus)

Samenvatting

The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.

Originele taal-2	English
Pagina's (van-tot)	193-203
Aantal pagina's	11
Tijdschrift	Lancet Oncology
Volume	11
Nummer van het tijdschrift	2
Status	Published - feb.-2010

Handle.net

Permanente koppeling

Citeer dit

@article{c0c3394b9c3a4491a6965f81596992aa,

title = "The metabolic syndrome in cancer survivors",

abstract = "The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.",

keywords = "ACUTE LYMPHOBLASTIC-LEUKEMIA, LONG-TERM SURVIVORS, GROWTH-HORMONE DEFICIENCY, HEMATOPOIETIC-CELL TRANSPLANTATION, DISSEMINATED TESTICULAR CANCER, CHILDHOOD BRAIN CANCER, BODY-MASS INDEX, ADULT SURVIVORS, BREAST-CANCER, CARDIOVASCULAR-DISEASE",

author = "{de Haas}, {Esther C.} and Oosting, {Sjoukje F.} and Lefrandt, {Joop D.} and Wolffenbuttel, {Bruce H. R.} and Sleijfer, {Dirk Th} and Gietema, {Jourik A.}",

year = "2010",

month = feb,

language = "English",

volume = "11",

pages = "193--203",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "ELSEVIER SCIENCE INC",

number = "2",

}

TY - JOUR

T1 - The metabolic syndrome in cancer survivors

AU - de Haas, Esther C.

AU - Oosting, Sjoukje F.

AU - Lefrandt, Joop D.

AU - Wolffenbuttel, Bruce H. R.

AU - Sleijfer, Dirk Th

AU - Gietema, Jourik A.

PY - 2010/2

Y1 - 2010/2

N2 - The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.

AB - The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.

KW - ACUTE LYMPHOBLASTIC-LEUKEMIA

KW - LONG-TERM SURVIVORS

KW - GROWTH-HORMONE DEFICIENCY

KW - HEMATOPOIETIC-CELL TRANSPLANTATION

KW - DISSEMINATED TESTICULAR CANCER

KW - CHILDHOOD BRAIN CANCER

KW - BODY-MASS INDEX

KW - ADULT SURVIVORS

KW - BREAST-CANCER

KW - CARDIOVASCULAR-DISEASE

M3 - Review article

SN - 1470-2045

VL - 11

SP - 193

EP - 203

JO - Lancet Oncology

JF - Lancet Oncology

IS - 2

ER -